[1]
|
R. J. Ellis, D. Rosario, D. B. Clifford, et al., “Continued High Prevalence and Adverse Clinical Impact of Human Immunodeficiency Virus-Associated Sensory Neuropathy in the Era of Combination Antiretroviral Therapy: The CHARTER Study,” Archives of Neurology, Vol. 67, No. 5, 2010, pp. 552-558. doi:10.1001/archneurol.2010.76
|
[2]
|
J. Robinson-Papp, B. Gelman, I. Grant, E. Singer, G. Gensler and S. Morgello, “Substance Abuse Increases the Risk of Neuropathy in an HIV-Infected Cohort,” Muscle Nerve, Vol. 45, No. 4, 2012, pp. 471-476.
doi:10.1002/mus.23231
|
[3]
|
S. R. Evans, R. J. Ellis, H. Chen, et al., “Peripheral Neuropathy in HIV: Prevalence and Risk Factors,” AIDS, Vol. 25, No. 7, 2011, pp. 919-928.
doi:10.1097/QAD.0b013e328345889d
|
[4]
|
M. Polydefkis, C. T. Yiannoutsos, B. A. Cohen, et al., “Reduced Intraepidermal Nerve Fiber Density in HIV-Associated Sensory Neuropathy,” Neurology, Vol. 58, No. 1, 2002, pp. 115-119. doi:10.1212/WNL.58.1.115
|
[5]
|
P. A. Low, “Composite Autonomic Scoring Scale for Laboratory Quantification of Generalized Autonomic Failure,” Mayo Clinic Proceedings, Vol. 68, No. 8, 1993, pp. 748-752.
|
[6]
|
G. A. Suarez, T. L. Opfer-Gehrking, K. P. Offord, E. J. Atkinson, P. C. O’Brien and P. A. Low, “The Autonomic Symptom Profile: A New Instrument to Assess Autonomic Symptoms,” Neurology, Vol. 52, No. 3,1999, pp. 523-528. doi:10.1212/WNL.52.3.523
|
[7]
|
S. Morgello, L. Estanislao, D. Simpson, et al., “HIV-Associated Distal Sensory Polyneuropathy in the Era of Highly Active Antiretroviral Therapy: The Manhattan HIV Brain Bank,” Archives of Neurology, Vol. 61, No. 4, 2004, pp. 546-551. doi:10.1001/archneur.61.4.546
|
[8]
|
C. Compostella, L. Compostella and R. D’Elia, “Cardiovascular Autonomic Neuropathy in HIV-Positive African Patients,” Minerva Cardioangiologica, Vol. 56, No. 4, 2008, pp. 417-428.
|
[9]
|
D. C. Chow, R. Wood, J. Choi, et al., “Cardiovagal Autonomic Function in HIV-Infected Patients with Unsuppressed HIV Viremia,” HIV Clinical Trials, Vol. 12, No. 3, 2011, pp. 141-150. doi:10.1310/hct1203-141
|
[10]
|
G. Askgaard, U. S. Kristoffersen, J. Mehlsen, G. Kronborg, A. Kjaer and A. M. Lebech, “Decreased Heart Rate Variability in HIV Positive Patients Receiving Antiretroviral Therapy: Importance of Blood Glucose and Cholesterol,” PLoS One, Vol. 6, No. 5, 2011, Article ID: e20196.
doi:10.1371/journal.pone.0020196
|
[11]
|
R. Freeman, M. S. Roberts, L. S. Friedman and C. Broadbridge, “Autonomic Function and Human Immunodeficiency Virus Infection,” Neurology, Vol. 40, No. 4, 1990, pp. 575-580. doi:10.1212/WNL.40.4.575
|
[12]
|
S. Ruttimann, P. Hilti, G. A. Spinas and U. C. Dubach, “High Frequency of Human Immunodeficiency Virus-Associated Autonomic Neuropathy and More Severe Involvement in Advanced Stages of Human Immunodeficiency Virus Disease,” Archives of Internal Medicine, Vol. 151, No. 12, 1991, pp. 2441-2443.
doi:10.1001/archinte.1991.00400120079013
|